BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 32903446)

  • 1. Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy.
    Vera KA; McConville M; Kyba M; Keller-Ross ML
    Front Physiol; 2020; 11():1008. PubMed ID: 32903446
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Resting metabolic rate in adults with facioscapulohumeral muscular dystrophy.
    Vera K; McConville M; Kyba M; Keller-Ross M
    Appl Physiol Nutr Metab; 2021 Sep; 46(9):1058-1064. PubMed ID: 33735584
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Body composition reference ranges in community-dwelling adults using dual-energy X-ray absorptiometry: the Australian Body Composition (ABC) Study.
    Kirk B; Bani Hassan E; Brennan-Olsen S; Vogrin S; Bird S; Zanker J; Phu S; Meerkin JD; Heymsfield SB; Duque G
    J Cachexia Sarcopenia Muscle; 2021 Aug; 12(4):880-890. PubMed ID: 33991068
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Body composition in long-term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence: A focus on sarcopenic obesity.
    Marriott CJC; Beaumont LF; Farncombe TH; Cranston AN; Athale UH; Yakemchuk VN; Webber CE; Barr RD
    Cancer; 2018 Mar; 124(6):1225-1231. PubMed ID: 29231963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sarcopenia definitions considering body size and fat mass are associated with mobility limitations: the Framingham Study.
    Dufour AB; Hannan MT; Murabito JM; Kiel DP; McLean RR
    J Gerontol A Biol Sci Med Sci; 2013 Feb; 68(2):168-74. PubMed ID: 22503991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exercise Intolerance in Facioscapulohumeral Muscular Dystrophy.
    Vera KA; McConville M; Glazos A; Stokes W; Kyba M; Keller-Ross M
    Med Sci Sports Exerc; 2022 Jun; 54(6):887-895. PubMed ID: 35195100
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sarcopenia, sarcopenic obesity, and functional impairments in older adults: National Health and Nutrition Examination Surveys 1999-2004.
    Batsis JA; Mackenzie TA; Lopez-Jimenez F; Bartels SJ
    Nutr Res; 2015 Dec; 35(12):1031-9. PubMed ID: 26472145
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bioelectrical impedance analysis as an alternative to dual-energy x-ray absorptiometry in the assessment of fat mass and appendicular lean mass in patients with obesity.
    Ballesteros-Pomar MD; González-Arnáiz E; Pintor-de-la Maza B; Barajas-Galindo D; Ariadel-Cobo D; González-Roza L; Cano-Rodríguez I
    Nutrition; 2022 Jan; 93():111442. PubMed ID: 34482097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sarcopenic Obesity in Chronic Kidney Disease: Challenges in Diagnosis Using Different Diagnostic Criteria.
    Bellafronte NT; de Queirós Mattoso Ono A; Chiarello PG
    Med Princ Pract; 2021; 30(5):477-486. PubMed ID: 34082433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sarcopenia, sarcopenic obesity and inflammation: Results from the 1999-2004 National Health and Nutrition Examination Survey.
    Batsis JA; Mackenzie TA; Jones JD; Lopez-Jimenez F; Bartels SJ
    Clin Nutr; 2016 Dec; 35(6):1472-1483. PubMed ID: 27091774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenic Obesity in Adults With Spinal Cord Injury: A Cross-Sectional Study.
    Pelletier CA; Miyatani M; Giangregorio L; Craven BC
    Arch Phys Med Rehabil; 2016 Nov; 97(11):1931-1937. PubMed ID: 27282328
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disentangling the body weight-bone mineral density association among breast cancer survivors: an examination of the independent roles of lean mass and fat mass.
    George SM; McTiernan A; Villaseñor A; Alfano CM; Irwin ML; Neuhouser ML; Baumgartner RN; Baumgartner KB; Bernstein L; Smith AW; Ballard-Barbash R
    BMC Cancer; 2013 Oct; 13():497. PubMed ID: 24161130
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenic obesity assessed using dual energy X-ray absorptiometry (DXA) can predict cardiovascular disease in patients with type 2 diabetes: a retrospective observational study.
    Fukuda T; Bouchi R; Takeuchi T; Tsujimoto K; Minami I; Yoshimoto T; Ogawa Y
    Cardiovasc Diabetol; 2018 Apr; 17(1):55. PubMed ID: 29636045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sarcopenia and sarcopenic obesity in patients with muscular dystrophy.
    Merlini L; Vagheggini A; Cocchi D
    Front Aging Neurosci; 2014; 6():274. PubMed ID: 25339901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The relationship between regional body composition and quantitative strength in facioscapulohumeral muscular dystrophy (FSHD).
    Skalsky AJ; Abresch RT; Han JJ; Shin CS; McDonald CM
    Neuromuscul Disord; 2008 Nov; 18(11):873-80. PubMed ID: 18818077
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Total and regional relationship between lean and fat mass with increasing adiposity--impact for the diagnosis of sarcopenic obesity.
    Schautz B; Later W; Heller M; Müller MJ; Bosy-Westphal A
    Eur J Clin Nutr; 2012 Dec; 66(12):1356-61. PubMed ID: 23031852
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A technique to assess body composition and sarcopenia using DXA: application for an obese population.
    Evans EM; Misic MM; Mallard DM
    Eur J Clin Nutr; 2010 Feb; 64(2):218-20. PubMed ID: 19904294
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequency and Functional Consequences of Low Appendicular Lean Mass and Sarcopenic Obesity in Patients with Asthma Referred for Pulmonary Rehabilitation.
    Meys R; Machado FVC; Spruit MA; Stoffels AAF; van Hees HWH; van den Borst B; Klijn PH; Burtin C; Pitta F; Franssen FME
    Obes Facts; 2023; 16(5):435-446. PubMed ID: 37232056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum: Sarcopenic Obesity in Facioscapulohumeral Muscular Dystrophy.
    Vera K; McConville M; Kyba M; Keller-Ross M
    Front Physiol; 2022; 13():908605. PubMed ID: 35574474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lean tissue mass measurements by dual-energy X-ray absorptiometry and associations with strength and functional outcome measures in facioscapulohumeral muscular dystrophy.
    Wang LH; Leung DG; Wagner KR; Lowry SJ; McDermott MP; Eichinger K; Higgs K; Walker M; Lewis L; Martens WB; Mul K; Sansone VA; Shieh P; Elsheikh B; LoRusso S; Butterfield RJ; Johnson N; Preston MR; Messina C; Carraro E; Tawil R; Statland J;
    Neuromuscul Disord; 2023 Sep; 33(9):63-68. PubMed ID: 37400350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.